FOOT AND MOUTH DISEASE

FOOT AND MOUTH DISEASE was reported 57 times

FOOT AND MOUTH DISEASE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Tissue-nonspecific Alkaline Phosphatase [EPC] 1 0.0001
1 Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] 1 0.0001
2 GLP-2 Analog [EPC] 1 0.0001
3 Parenteral Iron Replacement [EPC] 1 0.0001
4 Human Immunoglobulin G [EPC] 1 0.0000
5 Provitamin D2 Compound [EPC] 1 0.0000
6 B Lymphocyte Stimulator-specific Inhibitor [EPC] 1 0.0000
7 Angiotensin Converting Enzyme Inhibitor [EPC] 4 0.0000
8 Interleukin-17A Antagonist [EPC] 1 0.0000
9 Anti-IgE [EPC] 2 0.0000
10 Ester Local Anesthetic [EPC] 1 0.0000
11 Complement Inhibitor [EPC] 1 0.0000
12 Antidote [EPC] 1 0.0000
13 Potassium Channel Blocker [EPC] 1 0.0000
14 Non-Standardized Chemical Allergen [EPC] 1 0.0000
15 Catecholamine [EPC] 1 0.0000
16 Histamine-1 Receptor Antagonist [EPC] 1 0.0000
17 Integrin Receptor Antagonist [EPC] 1 0.0000
18 Amide Local Anesthetic [EPC] 1 0.0000
19 Folate Analog Metabolic Inhibitor [EPC] 5 0.0000
20 Nucleoside Metabolic Inhibitor [EPC] 3 0.0000
21 Purine Antimetabolite [EPC] 1 0.0000
22 Antiarrhythmic [EPC] 1 0.0000
23 Tumor Necrosis Factor Blocker [EPC] 10 0.0000
24 Vitamin D [EPC] 3 0.0000
25 Interleukin-23 Antagonist [EPC] 1 0.0000
26 Vitamin B12 [EPC] 3 0.0000
27 Vitamin C [EPC] 3 0.0000
28 Kinase Inhibitor [EPC] 3 0.0000
29 HMG-CoA Reductase Inhibitor [EPC] 2 0.0000
30 Mood Stabilizer [EPC] 1 0.0000
31 Anti-epileptic Agent [EPC] 1 0.0000
32 CD20-directed Cytolytic Antibody [EPC] 1 0.0000
33 Angiotensin 2 Receptor Blocker [EPC] 1 0.0000
34 Corticosteroid [EPC] 4 0.0000
35 Nonsteroidal Anti-inflammatory Drug [EPC] 4 0.0000
36 Interleukin-4 Receptor alpha Antagonist [EPC] 1 0.0000
37 Platelet Aggregation Inhibitor [EPC] 1 0.0000
38 Proton Pump Inhibitor [EPC] 1 0.0000
39 Benzodiazepine [EPC] 1 0.0000